Tenofovir

Products Tenofovir is commercially available in the form of film-coated tablets (Viread, combination products, generics). It has been approved in many countries since 2002. It is also used to treat chronic hepatitis B. This article refers to HIV. Structure and properties Tenofovir (C9H14N5O4P, Mr = 287.2 g/mol) is present in drugs in the form of … Tenofovir

Tenoxicam

Products Tenoxicam is commercially available in the form of film-coated tablets (Tilcotil). It has been approved in many countries since 1986. Structure and properties Tenoxicam (C13H11N3O4S2, Mr = 337.4 g/mol) belongs to the oxicams and is a thienothiazine derivative. It exists as a yellow crystalline powder that is practically insoluble in water. Lornoxicam (Xefo) is … Tenoxicam

Phosphodiesterase-5 Inhibitors

Products Phosphodiesterase-5 inhibitors are commercially available in the form of film-coated tablets and meltable tablets. Sildenafil (Viagra) was the first active ingredient from this group to be approved in the United States, the EU, and many countries in 1998. Generics are also available today. Sildenafil was originally to be developed by Pfizer for the treatment … Phosphodiesterase-5 Inhibitors

Simvastatin: Drug Effects, Side Effects, Dosage and Uses

Products Simvastatin is commercially available in the form of film-coated tablets (Zocor, generics). It is also combined fixed with ezetimibe (Inegy, generic). Simvastatin has been approved in many countries since 1990. Structure and properties Simvastatin (C25H38O5, Mr = 418.6 g/mol) exists as a white crystalline powder that is practically insoluble in water. It is a … Simvastatin: Drug Effects, Side Effects, Dosage and Uses

Siponimod

Products Siponimod was approved in film-coated tablet form in the United States in 2019 and in many countries in 2020 (Mayzent). Structure and properties Siponimod (C29H35F3N2O3, Mr = 516.6 g/mol) is present in the drug as a 2:1 co-crystal with the fumaric acid and as a white powder. The drug was developed starting from fingolimod, … Siponimod

Sitagliptin

Products Sitagliptin is commercially available in film-coated tablet form as a monopreparation (Januvia) and as a fixed combination with metformin (Janumet, Janumet XR). It was approved in many countries in 2007 as the first representative of the gliptins. The combination with simvastatin is not yet registered in many countries (Juvisync). Generics were approved in 2018. … Sitagliptin

Mycophenolate Mofetil

Products Mycophenolate mofetil is commercially available in the form of film-coated tablets, capsules, as an injectable, and as a suspension (CellCept, generics). It has been approved in many countries since 1995. Structure and properties Mycophenolate mofetil (C23H31NO7, Mr = 433.5 g/mol) exists as a white crystalline powder and is practically insoluble in water. It is … Mycophenolate Mofetil

Ponatinib

Products Ponatinib is commercially available in film-coated tablet form (Iclusig). It was approved in the EU in 2013 and in many countries in 2014. Structure and properties Ponatinib (C29H27F3N6O, Mr = 532.6 g/mol) is present in the drug as ponatinib hydrochloride, a white to yellow powder whose water solubility decreases with increasing pH. It is … Ponatinib

Saquinavir

Products Saquinavir is commercially available in the form of film-coated tablets (Invirase). It has been approved in many countries since 1996 (United States: 1995). Structure and properties Saquinavir (C38H50N6O5, Mr = 670.8 g/mol) is present in the drug as saquinavir mesilate, a white, weakly hygroscopic powder that is practically insoluble in water. Effects Saquinavir (ATC … Saquinavir

Imatinib

Products Imatinib is commercially available in the form of film-coated tablets (Gleevec, Gleevec GIST, generic). It has been approved in many countries since 2001. Generics came on the market in 2016. They were not approved for the treatment of gastrointestinal stromal tumors (GIST) because this indication was still protected by a patent. In 2017, imatinib … Imatinib

Alogliptin

Products Alogliptin is commercially available in film-coated tablet form as a monopreparation (Vipidia) and as a fixed combination with metformin (Vipdomet). It was approved in many countries in 2013. Structure and properties Alogliptin (C18H21N5O2, Mr = 339.4 g/mol) is present in drugs as alogliptin benzoate, a white crystalline powder that is sparingly soluble in water. … Alogliptin

Alpelisib

Products Alpelisib was approved in the United States in 2019 and in many countries in 2020 in film-coated tablet form (Piqray). Structure and properties Alpelisib (C19H22F3N5O2S, Mr = 441.5 g/mol) exists as a white powder. Effects Alpelisib (ATC L01XX65) has antiproliferative and antitumor properties. The effects are due to inhibition of the α-subunit of phosphatidylinositol … Alpelisib